Pfizer (NYSE:PFE) - Page 2

stock symbol ticker

The 4 Stocks That Dominated the Market on Wednesday

February 5, 2014: Markets opened lower on Wednesday following the report from ADP that nonfarm payrolls had risen less than expected in January. And unlike yesterday, the Japanese yen gathered ...
Read Full Story »
pills

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Drug giant Merck & Co. Inc. (NYSE: MRK) reported fourth-quarter and full-year 2013 results before markets opened Wednesday morning. The company reported quarterly adjusted diluted earnings per share (EPS) of ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Dominated the Market on Tuesday

February 4, 2014: Markets opened higher on Tuesday following a crushing on Monday that saw all three major indexes put up at least a 2% loss on the day. Equities ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Earnings season is already on the back-nine, and now analysts and investors are adjusting their positions and outlooks now that the stock market has started to pull back. 24/7 Wall ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More

Earnings season is peaking and analysts are making many ratings adjustments in their 2014 outlooks. 24/7 Wall St. reviews dozens of Wall Street analyst research reports each morning. Some cover ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Dominated the Market on Tuesday

January 28, 2014: Markets opened mixed on Tuesday, with the Nasdaq trailing at the opening bell as shares in Apple sold off following last night’s earnings report. Today’s economic data ...
Read Full Story »
Pfizer logo

Pfizer Delivers on Earnings, Sets 2014 Guidance

Pfizer Inc. (NYSE: PFE) has managed to handily beat consensus fourth-quarter earnings expectations, at least on the surface. Earnings came to $0.56 per share on $13.6 billion in sales. Thomson ...
Read Full Story »
Facebook logo - new

Facebook Cements Position Among Most Traded Stocks

Facebook Inc. (NASDAQ: FB) has barely been listed at a public company for two years, yet it has become one of the most widely traded stocks on any U.S. exchange. ...
Read Full Story »
Pfizer logo

Will Pfizer Stop-Smoking Pill Hurt Tobacco Giants?

It is not unusual for approved drugs to receive ongoing study tests over safety and efficacy. That is the case for Pfizer Inc. (NYSE: PFE) and its stop-smoking drug Chantix. ...
Read Full Story »
NYSE-flag

5 Stocks That Dominated the Market on Tuesday

The stock gods decided to buy the dip on Tuesday, a day after the biggest sell-off in about three months. Despite a lack of market-moving economic reports, the losses of ...
Read Full Story »
Bull and Bear

The 2014 DJIA Bull and Bear Case: Boeing, Verizon, Coke, JPMorgan, Pfizer and More

We are now well  past the end of 2013, and many strategists have mixed targets for the stock and bond markets in 2014. The last year brought gains of 26.5% ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: BlackBerry, Micron, Target, 3D Printers and More

The first full trading week of 2014 has come along with many key analyst rating changes. Investors also continue to position their portfolios for the year ahead. 24/7 Wall St. reviews many ...
Read Full Story »
pills

The Bullish and Bearish Case for Pfizer and Merck in 2014

With a new year comes new expectations. The stock market gains in 2013 were massive, with the S&P 500 index rising by more than 29% and the Dow Jones Industrial ...
Read Full Story »
Wall St Bull statue

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

2014 is upon us, and that means that investors have started positioning their portfolios for the year ahead. 24/7 Wall St. reviews many analyst calls each day in order to ...
Read Full Story »
gavel

Teva Secures Rights to Launch Generic Viagra

Pfizer Inc.'s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020, but Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has acquired rights to ...
Read Full Story »